About CANNTAB THERAPEUTICS LIMITED
Sector
CEO
Richard Goldstein
Headquarters
Markham
Website
Founded
2010
FIGI
BBG00GTQYW34
Canntab Therapeutics Ltd. is a biopharmaceutical company. It engages in the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. The firm's products include nanoemulsion technology, multi-particulate drug delivery systems, specialty gel capsules, propriety granulation technology, oral quick dissolve tablet, instant release solid oral, extended release solid oral, and bi-layer solid oral. The company was founded by Richard Goldstein and Jeffrey W. Renwick on May 31, 2010 and is headquartered in Markham, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange CANNTAB THERAPEUTICS LTD. stocks are traded under the ticker TBF1.
Yes, you can track CANNTAB THERAPEUTICS LTD. financials in yearly and quarterly reports right on TradingView.
No, TBF1 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, TBF1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CANNTAB THERAPEUTICS LTD. stock right from TradingView charts — choose your broker and connect to your account.